Bookmark

Add to MyYahoo RSS

GlaxoSmithKline News

News on GlaxoSmithKline (Ticker: GSK) continually updated from thousands of sources around the net.

4 hrs ago | Brand Republic

Wunderman wins global GSK pitch

GlaxoSmithKline is set to appoint Wunderman as the lead agency on its global digital advertising account after a pitch that began last year.

Comment?

Related Topix: Wunderman, Advertising, Biotech, GlaxoSmithKline, Healthcare Industry

Wed Aug 20, 2014

Sys-Con Media

North American Pharma-Biotech Sector to Wrap Up Construction on 157...

Midway through the third quarter of 2014, the Pharmaceutical-Biotech Industry is busy finishing an impressive array of capital construction projects.

Comment?

Related Topix: Biotech, Medicine, GlaxoSmithKline, Healthcare Industry, BioMed Realty Trust, Sugar Land, TX

BioSpace

Pozen, Inc. Announces U.S. Rights For TREXIMET?? Have Been Acquired By Pernix Therapeutics, Inc.

POZEN Inc. , a pharmaceutical company committed to transforming medicine that transforms lives, today announced that the acquisition of all of GlaxoSmithKline's rights to TreximetA have been acquired by Pernix Therapeutics Holdings, Inc. .

Comment?

Related Topix: Biotech, Medicine, Pozen, Healthcare Industry

Benzinga

GlaxoSmithKline Receives FDA Approval For Arnuity Ellipta In US For Treatment Of Asthma

GlaxoSmithKline plc today announced that the FDA has approved Arnuitya ElliptaA , a once-daily inhaled corticosteroid medicine for maintenance treatment of asthma as prophylactic therapy in patients aged 12 years and older.

Comment?

Related Topix: Medicine, Asthma, Health, Biotech, GlaxoSmithKline, Healthcare Industry, Fluticasone (generic), Flovent

Seeking Alpha

GlaxoSmithKline: The Bad Isn't All That Bad

But is this merely a buying opportunity for a solid company? It trades as one of the cheapest pharma companies around and offers one of the best dividend yields.

Comment?

Related Topix: Biotech, Medicine, GlaxoSmithKline, Healthcare Industry

Wall Street Journal

Mylan Edges Toward Glaxo Drugs

U.S. generic drugs company Mylan Inc., private equity groups TPG Capital LLP, Advent International, KKR & Co L.P., and Warburg Pincus LLC, and some Indian drug makers have made it through to the second round of bidding for a portfolio of mature drugs being sold by GlaxoSmithKline PLC, according to people familiar with the sales process.

Comment?

Related Topix: Startups, Warburg Pincus, Biotech, Medicine, GlaxoSmithKline, Healthcare Industry

The Motley Fool

If You Want Dividend Income, Look No Further than GlaxoSmithKline plc Stock

Dividends: They're the cornerstone to any healthy, long-term-focused portfolio. But when it comes to the health care industry, securing dividend income isn't as easy as it sounds.

Comment?

Related Topix: Biotech, Medicine, GlaxoSmithKline, Healthcare Industry, Food and Drug Administration

TheStreet.com

Yes, Call it a Comeback: Amicus Fabry Drug Posts Big Study Win

Your browser is not supported. Please upgrade to one of the following browsers: Google Chrome Mozilla Firefox Apple Safari Microsoft Internet Explorer 8+ You may proceed to the site by clicking here , however some pages might not work correctly.

Comment?

Related Topix: Mozilla, Biotech, Medicine, GlaxoSmithKline, Healthcare Industry, Genetics

TheStreet.com

Yes, Call it a Comeback: Amicus Fabry Drug Posts Big Study Win

CEO John Crowley came close to permanently shelving his company's experimental Fabry disease therapy following disappointing results from a late-stage study in December 2012 and the departure of partner GlaxoSmithKline about one year later.

Comment?

Related Topix: Biotech, Medicine, GlaxoSmithKline, Healthcare Industry, Genetics, Business News

Tue Aug 19, 2014

Business Journal

Sanford-Burnham Medical Research Institute gets new leader

Sanford-Burnham Medical Research Institute on Aug. 19 announced it has selected Dr. Perry Nisen as CEO at its La Jolla, Calif.-based headquarters.

Comment?

Related Topix: United Kingdom, Greater London County, England, Biotech, Medicine, GlaxoSmithKline, Healthcare Industry

Seeking Alpha

GlaxoSmithKline: To Buy Or Not To Buy?

GlaxoSmithKline is a global pharmaceutical company known for producing a variety of drugs and consumer goods such as AquaFresh toothpaste, Tums gastrointestinal aid, and Amoxil antibiotic.

Comment?

Related Topix: Biotech, Medicine, GlaxoSmithKline, Healthcare Industry, Amoxicillin (generic), Amoxil, Trimox, Diabetes, Health

Mon Aug 18, 2014

GuruFocus.com

Guru Stocks at 52-Week Lows: PFE, GSK, VOD, EC, MFG

According to GuruFocus list of 52-week lows , these Guru stocks have reached their 52-week lows.

Comment?

Related Topix: Financial Markets, Pfizer, Biotech, Medicine, Healthcare Industry, GlaxoSmithKline, Vodafone Group, Telecom

Mother Jones

But researchers are ramping up efforts in the hope of saving lives in the future.

With the death toll in the worst Ebola outbreak in history exceeding 1,000, pharmaceutical companies and health authorities are sprinting to develop new drugs and vaccines.

Comment?

Related Topix: Biotech, Medicine, GlaxoSmithKline, Healthcare Industry, Sierra Leone, World News, Africa, Tulane University

LIRNEasia

Mobile may follow Pharma to break Big Data taboo

Turnover of GlaxoSmithKline was US$44 billion in 2013 and it annually spends $6.5 billion in R&D.

Comment?

Related Topix: Biotech

Business Journal

Duke: Using experimental drug in Ebola outbreak could 'prove disastrous'

It's a debate federal regulators and drug companies have all the time. Should a company with an experimental drug give it to people in need to potentially save their lives, or should regulators make sure the drug is safe before it does any more harm? It's a question that seems to always result in a lose-lose situation.

Comment?

Related Topix: Medicine, Biotech, Healthcare Industry, BioCryst Pharmaceuticals

Pollution Online

EPA Settlement With GlaxoSmithKline Protects Community Health And The ...

In a settlement with the U.S. Environmental Protection Agency, GlaxoSmithKline, LLC has agreed to properly manage the hazardous waste at its research and development facility in King of Prussia, Pa.

Comment?

Related Topix: Environmental Law, Law, Environment, Science, U.S. Environmental Protection Agency, Biotech

Sun Aug 17, 2014

NewsTarget.com

New malaria vaccine doesn't work most of the time, but manufacturer says it's good enough to sell

There's a good chance that the vast majority of people who receive it won't derive any benefits whatsoever.

Comment?

Related Topix: Malaria, Health, Biotech, Centers for Disease Control and Prevention

AmericanBankingNews.com

GlaxoSmithKline plc Receives Consensus Recommendation of "Hold" from Brokerages

Shares of GlaxoSmithKline plc have earned an average recommendation of "Hold" from the twenty-two analysts that are presently covering the company, AnalystRatings.NET reports .

Comment?

Related Topix: Biotech, Medicine, GlaxoSmithKline, Healthcare Industry

Thu Aug 14, 2014

Seeking Alpha

Why GlaxoSmithKline Is A Tempting Buy

By now, most investors know all the problems facing pharmaceutical giant GlaxoSmithKline .

Comment?

Related Topix: Biotech, Medicine, GlaxoSmithKline, Healthcare Industry, Pfizer, AstraZeneca, AstraZeneca Group

Business Journal

Duke: Using experimental drug in Ebola outbreak could 'prove disastrous'

It's a debate federal regulators and drug companies have all the time. Should a company with an experimental drug give it to people in need to potentially save their lives, or should regulators make sure the drug is safe before it does any more harm? It's a question that seems to always result in a lose-lose situation.

Comment?

Related Topix: Medicine, Biotech, Healthcare Industry, BioCryst Pharmaceuticals

•••
•••
•••
•••
•••

Ashburn Jobs

•••
•••
•••
•••